Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

SABR-ATAC: A Trial of TGF-beta Inhibition and Stereotactic Ablative Radiotherapy for Early Stage Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02581787
Recruitment Status : Active, not recruiting
First Posted : October 21, 2015
Last Update Posted : September 21, 2021
Sponsor:
Collaborator:
Varian
Information provided by (Responsible Party):
Maximilian Diehn, Stanford University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 28, 2020
Estimated Study Completion Date : December 2021